Recent News
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception20231130144754
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception Orlando...
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception20231130144636
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
Orlando, FL, Nov. 30, 2023 — Biostax Corp., (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech developme...
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro20231115143241
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro Orlando, FL, November 15, 2023 (GLOBE NEWS...
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors20231102141249
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
Orlando, FL, Nov. 02, 2023 — Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development...
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors20231102135413
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors Orlando, FL, November. 2, 2023 (GLOBE N...
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment20231024131722
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Mark...
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment20231024131648
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
ORLANDO, Fla., Oct. 24, 2023 — Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solut...
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky20230914132140
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) ...
Load more
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception20231130144754
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception Orlando...
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception20231130144636
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
Orlando, FL, Nov. 30, 2023 — Biostax Corp., (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech developme...
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro20231115143241
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro Orlando, FL, November 15, 2023 (GLOBE NEWS...
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors20231102141249
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
Orlando, FL, Nov. 02, 2023 — Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development...
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors20231102135413
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors Orlando, FL, November. 2, 2023 (GLOBE N...
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment20231024131722
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Mark...
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment20231024131648
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
ORLANDO, Fla., Oct. 24, 2023 — Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solut...
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky20230914132140
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) ...
Load more
About Biostax
Biostax is a hub-and-spoke development engine powering efficient small-scale med-tech, pharmaceutical and biotechnology programs.
Investor Contacts
Company
1317 Edgewater Dr.
Suite 4882
Orlando
Florida
32804 United States
888 391-9355 (Phone)
info@biostax.net
Transfer Agent
Clear Trust, LLC
6540 Pointe Village Dr
Suite 205 Lutz, Florida 33558
Phone 813.235.4490
Fax 813.388.4549
ClearTrustTransfer.com
Inbox@ClearTrustTransfer.com